Arboretum Ventures

Arboretum relies on a geography-centric sourcing model anchored in the Midwest, particularly Ann Arbor. The firm draws deal flow from the region's concentration of major research universities, academic medical centers, and clinician-founders. This localized approach gives it access to healthcare start-ups that often fall outside the standard pipeline of coastal venture capital firms.

The firm operates across the early-stage spectrum, with a strategy that includes seed and start-up investments. Arboretum focuses on companies in their initial phases of development, providing capital during the period when a venture is moving from concept to early clinical or commercial validation.

Arboretum concentrates on healthcare, with specific attention paid to medical devices, diagnostics, and digital health. The firm's strategy prioritizes capital-efficient life-science companies that are developing tangible products or platforms for clinical use.

The Ann Arbor headquarters places the firm at the center of a robust research ecosystem that includes the University of Michigan. This proximity enables close partnerships with academic spin-outs and provides early visibility into innovations emerging from the Midwest's hospital systems and engineering labs, shaping a thesis that is distinct from typical venture hubs.

Arboretum's known posture is to make direct equity investments in early-stage companies, consistent with a standard venture capital model. There is no public evidence that the firm operates a fund-of-funds strategy or regularly participates as a limited partner in other venture funds.